Marketing analysis of the pharmaceutical market of antidiabetic drugs in Ukraine
Keywords:diabetes mellitus, medicines, pharmaceutical market, marketing analysis, assortment
Diabetes mellitus is an important public health issue. Statistics show a rapid growth in the number of patients each year, which increases the financial burden on the state’s economy. Therefore, systematic marketing monitoring of the pharmaceutical market of drugs for diabetes is appropriate and permanently relevant.
The aim of the research was to study the pharmaceutical market of antidiabetic drugs in Ukraine as of the first quarter of 2022.
Materials and methods. The nomenclature range of drugs was analyzed in accordance with the State Register and the Anatomical-Therapeutic-Chemical Classification. The objects of research were information on synthetic hypoglycemic drugs registered in Ukraine, as well as herbal medicines belonging to the category A10 “Antidiabetic drugs”. Analytical and comparative methods, as well as marketing analysis and generalization of information were applied.
Results. The structure of the pharmaceutical market of medicines from category A10 “Antidiabetic drugs” is formed by mono-drugs, their share is 84.2 %, while combined drugs make 12.9 %, and only 2.9 % belongs to medicinal plant raw materials and their mixtures. Among mono-drugs, the most numerous by the number of trade names is the group of sulfonylureas and biguanides, the percentage of which is 33.9 %. The pharmaceutical market of antidiabetic drugs in Ukraine is import-dependent, as the share of foreign medicines from 24 importing countries is 59.3 %. Domestic manufacturers of drugs for type 2 diabetes are 10 pharmaceutical companies, among which production output is dominated by JSC “Farmak” – 31.9 %. Preparations based on medicinal plant raw materials are manufactured by PJSC “Liktravy” and PJSC Pharmaceutical Factory “Viola” in the form of mixtures and medicinal raw materials.
Conclusions. The nomenclature ranges of drugs, which according to the ATC classification belong to the category A10 “Antidiabetic drugs”, are analyzed and the structure of the segment is described. The range of herbal antidiabetic drugs has been studied and their share in the structure of the pharmaceutical market of Ukraine has been determined. The prevalence of foreign-made drugs over domestic ones has been established.
Introduction: Standards of Medical Care in Diabetes-2021. (2021). Diabetes care, 44(Suppl 1), S1-S2. https://doi.org/10.2337/dc21-Sint
International Diabetes Federation. (2021). Diabetes Atlas. 10th edition. Brussels: IDF. http://www.diabetesatlas.org
International Diabetes Federation. (2021). Atlas: Diabet v Ukrayini [Atlas: Diabetes in Ukraine] (Vol. 1). Ukrainian Diabetes Federation "Diabetes and Life". [in Ukrainian]. https://diabetesatlas.com.ua/ua/pershe-vydannia
Public Health Center of Ukraine. (2021). Statystychni dani DZ "Tsentr medychnoi statystyky MOZ Ukrainy" [Statistical data of the Center of Medical Statistics of the Ministry of Health of Ukraine]. [in Ukrainian]. https://www.phc.org.ua/kontrol-zakhvoryuvan/neinfekciyni zakhvoryuvannya/diabet
Ministry of Health of Ukraine. (2022). Derzhavnyi reiestr likarskykh zasobiv Ukrainy [State register of medicines of Ukraine]. [in Ukrainian]. http://www.drlz.kiev.ua.11
Ministry of Health of Ukraine. (2022). Normatyvno-dyrektyvni dokumenty MOZ Ukrayiny [Regulatory documents of the Ministry of Health of Ukraine]. [in Ukrainian]. https://mozdocs.kiev.ua
Morion. (2022). Kompendium [Compendium]. [in Ukrainian]. http://compen-dium.com.ua
Bertin, E., Arner, P., Bolinder, J., & Hagström-Toft, E. (2001). Action of glucagon and glucagon-like peptide-1-(7-36) amide on lipolysis in human subcutaneous adipose tissue and skeletal muscle in vivo. The Journal of clinical endocrinology and metabolism, 86(3), 1229-1234. https://doi.org/10.1210/jcem.86.3.7330
How to Cite
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)